BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7279701)

  • 21. Carcinoembryonic antigen screening: pros and cons.
    Macdonald JS
    Semin Oncol; 1999 Oct; 26(5):556-60. PubMed ID: 10528904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma carcinoembryonic antigen (CEA) as an indicator for radical or palliative radiotherapy in patients with rectal cancer.
    Arnott SJ
    Cancer Detect Prev; 1983; 6(1-2):155-9. PubMed ID: 6192917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma.
    Nonaka M; Kataoka D; Yamamoto S; Bito A; Matsuoka J; Kawada T; Takaba T
    Ann Thorac Cardiovasc Surg; 2004 Oct; 10(5):281-4. PubMed ID: 15563262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoembryonic antigen in the assessment of lung cancer.
    Stokes TC; Belcher JR; Storring RA; Stevens JF; Long P; Miller AL
    Invest Cell Pathol; 1980; 3(4):383-7. PubMed ID: 7462019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer.
    Wolf RF; Cohen AM
    J Am Coll Surg; 1997 Jul; 185(1):60-4. PubMed ID: 9208962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
    Carpelan-Holmström MA; Haglund CH; Järvinen HJ; Roberts PJ
    Anticancer Res; 1996; 16(2):981-6. PubMed ID: 8687164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinoembryonic antigen as a prognostic indicator in the radiotherapeutic management of rectal cancer.
    Davey P; Arnott SJ; Sturgeon CM
    Eur J Surg Oncol; 1987 Feb; 13(1):17-20. PubMed ID: 2434361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CEA and the clinical course in advanced carcinoma of the uterine cervix (author's transl)].
    Braun P; Leyendecker G
    Geburtshilfe Frauenheilkd; 1982 Jun; 42(6):462-7. PubMed ID: 6921128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
    Yamamoto M; Maehara Y; Sakaguchi Y; Mine H; Yamanaka T; Korenaga D; Okamura T
    Hepatogastroenterology; 2004; 51(55):147-51. PubMed ID: 15011851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy.
    Falkson HC; van der Watt JJ; Portugal MA; Schoeman HS; Falkson G
    Cancer Treat Rep; 1979 Aug; 63(8):1303-9. PubMed ID: 476707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoiperative carcinoembryonic antigen level and prognosis in colorectal cancer.
    Chapuis PH; Newland RC; Payne JE; Macpherson JG; Pheils MT
    Med J Aust; 1980 Aug; 2(3):140-3. PubMed ID: 7421682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
    Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
    Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer.
    Ikeda Y; Mori M; Kajiyama K; Kamakura T; Maehara Y; Haraguchi Y; Sugimachi K
    Hepatogastroenterology; 1996; 43(11):1281-7. PubMed ID: 8908563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphography and CEA in the diagnosis of metastases in patients with stage IB cancer of the cervix.
    Kjorstad KE; Kolbenstvedt A; Drevvatne T; Orjaseter H
    Diagn Gynecol Obstet; 1980; 2(1):71-5. PubMed ID: 7472147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The usefulness of the quantitative evaluation of the plasma levels of the carcinoembryonic antigen (CEA) in patients with respiratory neoplasms (author's transl)].
    Richart C; Ruibal A; Monné J
    Med Clin (Barc); 1979 Oct; 73(6):239-41. PubMed ID: 232738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immuno-oncologic monitoring of patients with bronchial carcinoma. I. Carcinoembryonic antigen (CEA)].
    Mancuso M; Leonardo E; Sanfilippo B; Dogliotti C; Oliaro A; Maggi G
    Minerva Med; 1985 Jan; 76(1-2):15-9. PubMed ID: 3974915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma carcinoembryonic antigen in an Australian hospital population.
    Frost MA; Coates AS
    Med J Aust; 1976 Jun; 1(25):950-3. PubMed ID: 979758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
    Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
    J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.